Pre-emptive Low-dose Doxycycline During Anti-EGFR Treatment (STLDD-1)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology
ClinicalTrials.gov Identifier:
NCT01380262
First received: June 22, 2011
Last updated: June 24, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2011
  Estimated Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)